DME (psychedelic)

DME
Names
	Preferred IUPAC name 2-Amino-1-(3,4-dimethoxyphenyl)ethan-1-ol
	Other names 3,4-Dimethoxy-beta-hydroxyphenethylamine; 3,4-Dimethoxy-1-ethyl-(beta-hydroxy)amine
Identifiers
CAS Number	6924-15-8 ;
3D model (JSmol)	Interactive image; Interactive image;
ChemSpider	3088871 ;
PubChem CID	3863978;
UNII	F9TYB6AM4W;
CompTox Dashboard (EPA)	DTXSID50512380 ;
	InChI InChI=1S/C10H15NO3/c1-13-9-4-3-7(8(12)6-11)5-10(9)14-2/h3-5,8,12H,6,11H2,1-2H3 Key: WIUFFBGZBFVVDL-UHFFFAOYSA-N ; InChI=1/C10H15NO3/c1-13-9-4-3-7(8(12)6-11)5-10(9)14-2/h3-5,8,12H,6,11H2,1-2H3 Key: WIUFFBGZBFVVDL-UHFFFAOYAL;
	SMILES COc1cc(ccc1OC)C(O)CN; O(c1ccc(cc1OC)C(O)CN)C;
Properties
Chemical formula	C10H15NO3
Molar mass	197.234 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

DME (3,4-dimethoxy-beta-hydroxyphenethylamine) is a lesser-known psychedelic drug. It is the beta-hydroxy derivative of 3,4-dimethoxyphenethylamine. DME was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 115 mg, and the duration unknown. DME produces few to no effects.^[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of DME.